Contec Medical Systems Co., Ltd. (CONTEC) is a high-tech medical device manufacturer specializing in the research, development, production, and distribution of diagnostic and monitoring equipment. Established in 1996 and headquartered in the scenic coastal city of Qinhuangdao, Hebei Province, CONTEC is one of China’s largest R&D and production bases for medical devices.

In August 2020, CONTEC was officially listed on the Shenzhen Stock Exchange (Stock Code: 300869), marking a significant milestone in its growth and innovation journey. The company employs over 1,000 professionals and occupies a production area of 67,450 square meters, featuring integrated facilities for R&D, manufacturing, and global distribution.

CONTEC’s product portfolio spans more than 20 categories, including pulse oximeters, sphygmomanometers, ECG and EEG systems, ultrasound devices, patient monitors, and imaging equipment. The company holds over 100 national patents and 56 software copyrights, reflecting its commitment to innovation and technological advancement. All products meet international standards and have received certifications such as CE, FDA, and approvals in Canada, Japan, and Brazil.

The company is certified under ISO9001, ISO13485, and ISO14001, and complies with BSCI (Business Social Compliance Initiative) standards, ensuring quality, sustainability, and ethical manufacturing. With subsidiaries in the USA, Germany, and India, CONTEC has established a strong global presence and exports to over 130 countries and regions worldwide.

Guided by its philosophy of being people-oriented, innovative, and cooperative for win-win outcomes, CONTEC continues to leverage advanced technology and skilled talent to achieve sustainable growth. Its vision is to build a world-class enterprise through internationalization, modern management, and product diversification, contributing to the advancement of global healthcare.